Janice L. Holton

29.7k citations

242 papers · 17.7k indexed · 6 hit papers · h-index 71

Neurology top 0.02%
Physiology top 0.1%
Molecular Biology top 1%
Cellular and Molecular Neuroscience top 0.2%
Neurology top 0.05%

Co-authors: Tamás Révész Andrew J. Lees Tammaryn Lashley Henry Houlden Niall Quinn Helen Ling David R. Williams John Hardy
Topics: Parkinson's Disease Mechanisms and Treatments (129 papers)Alzheimer's disease research and treatments (64 papers)Neurological disorders and treatments (54 papers)
Cited by: Neurology Cellular and Molecular Neuroscience
Journals: Proceedings of the National Academy of Sciences The Lancet Journal of Biological Chemistry
Partner nations: United Kingdom United States Australia

In The Last Decade

Janice L. Holton

238 papers receiving 17.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

2008 1.3k citations Janice L. Holton, Andrew J. Lees et al. profile →
A common LRRK2 mutation in idiopathic Parkinson's disease

2005 575 citations Andrew Singleton, Andrew J. Lees et al. profile →
Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism

2005 517 citations David R. Williams, Rohan de Silva et al. Brain profile →
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease

2009 509 citations José Brás, Emma Deas et al. Brain profile →
Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?

2011 441 citations Laura Parkkinen, Sean S. O’Sullivan et al. Brain profile →
Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease

2019 200 citations Eduardo De Pablo‐Fernández, Andrew J. Lees et al. profile →

Peers

Countries citing papers authored by Janice L. Holton

Since Specialization

Citations

This map shows the geographic impact of Janice L. Holton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janice L. Holton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janice L. Holton more than expected).

Fields of papers citing papers by Janice L. Holton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janice L. Holton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janice L. Holton. The network helps show where Janice L. Holton may publish in the future.

Co-authorship network of co-authors of Janice L. Holton

This figure shows the co-authorship network connecting the top 25 collaborators of Janice L. Holton. A scholar is included among the top collaborators of Janice L. Holton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janice L. Holton. Janice L. Holton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Diagnosing Premotor Multiple System Atrophy 2022 ·Neurology ·Ekawat Vichayanrat,Fernanda Valério,(unknown),Eduardo De Pablo‐Fernández,Jalesh N. Panicker,Huw R. Morris,Kailash P. Bhatia,Viorica Chelban,Henry Houlden,Niall Quinn,Judith Navarro‐Otano,Yasuo Miki,Janice L. Holton,Thomas T. Warner,Christopher J. Mathias,Valeria Iodice	6
2	Neurodegenerative movement disorders: An epigenetics perspective and promise for the future 2021 ·Neuropathology and Applied Neurobiology ·(unknown),(unknown),Janice L. Holton,Conceição Bettencourt	18
3	Faster disease progression in Parkinson’s disease with type 2 diabetes is not associated with increased α‐synuclein, tau, amyloid‐β or vascular pathology 2021 ·Neuropathology and Applied Neurobiology ·Eduardo De Pablo‐Fernández,Robert J. Courtney,(unknown),Steve Gentleman,Janice L. Holton,Thomas T. Warner	22
4	Expanding the molecular and phenotypic spectrum of truncating MT-ATP6 mutations 2020 ·Neurology Genetics ·Enrico Bugiardini,Emanuela Bottani,Silvia Marchet,(unknown),Cristiane Benincá,Alejandro Horga,Cathy E. Woodward,Amanda Lam,Iain P. Hargreaves,Annapurna Chalasani,Alessandra Valerio,Eleonora Lamantea,Kerrie Venner,Janice L. Holton,Massimo Zeviani,Henry Houlden,Rosaline C. M. Quinlivan,Costanza Lamperti,Michael G. Hanna,Robert D. S. Pitceathly	25
5	Signs of Chronic Hypoxia Suggest a Novel Pathophysiological Event in α‐Synucleinopathies 2020 ·Movement Disorders ·Antonio Heras‐Garvin,(unknown),Sabine Eschlböck,Janice L. Holton,Gregor K. Wenning,Nadia Stefanova	12
6	The genetic and clinico‐pathological profile of early‐onset progressive supranuclear palsy 2019 ·Movement Disorders ·Edwin Jabbari,John Woodside,Manuela Tan,Nicola Pavese,Oliver Bandmann,Boyd Ghosh,Luke A. Massey,(unknown),Thomas T. Warner,Andrew J. Lees,Tamás Révész,Janice L. Holton,Nigel Williams,Donald G. Grosset,Huw R. Morris	16
7	Idiopathic inflammatory myopathy 2019 ·Neurology ·P.A.S. Olivier,Boél De Paepe,Eleonora Aronica,(unknown),Roos Colman,Anthony Amato,Dalia Dimitri,Eduard Gallardo,Romain K. Gherardi,Hans‐Hilmar Goebel,David Hilton‐Jones,Monika Hofer,Janice L. Holton,Henrik Daa Schrøder,Duygu Selcen,Werner Stenzel,Marjolein Visser,Jan De Bleecker	15
8	A novel TBK1 mutation in a family with diverse frontotemporal dementia spectrum disorders 2019 ·Molecular Case Studies ·Ruth Lamb,Jonathan D. Rohrer,Raquel Real,Steven Lubbe,Adrian J. Waite,Derek J. Blake,R. J. Walters,Tammaryn Lashley,Tamás Révész,Janice L. Holton,Huw R. Morris	22
9	Young‐onset multiple system atrophy: Clinical and pathological features 2018 ·Movement Disorders ·Amit Batla,Eduardo De Pablo‐Fernández,Roberto Erro,Martin M. Reich,Giovanna Calandra–Buonaura,(unknown),Bettina Balint,Helen Ling,(unknown),Pietro Cortelli,Jens Volkmann,Niall Quinn,Janice L. Holton,Thomas T. Warner,Kailash P. Bhatia	24
10	Transthyretin V122I amyloidosis with clinical and histological evidence of amyloid neuropathy and myopathy 2015 ·Neuromuscular Disorders ·(unknown),Ana L. Pelayo‐Negro,Zane Jaunmuktane,R. Scalco,David F. Hutt,(unknown),(unknown),Sebastian Brandner,Janice L. Holton,J. Blake,Carol Whelan,Ashutosh Wechalekar,Julian D. Gillmore,Philip N. Hawkins,Mary M. Reilly	19
11	Parkinson's disease without nigral degeneration: a pathological correlate of scans without evidence of dopaminergic deficit (SWEDD)? 2015 ·Journal of Neurology Neurosurgery & Psychiatry ·Helen Ling,(unknown),(unknown),Laura Silveira‐Moriyama,Tamás Révész,Janice L. Holton,Catherine Strand,Kenneth Davey,Kin Y. Mok,James M. Polke,Andrew J. Lees	10
12	A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis 2014 ·BMJ Open ·Stefen Brady,Waney Squier,C. Sewry,Michael G. Hanna,David Hilton‐Jones,Janice L. Holton	70
13	205th ENMC International Workshop: Pathology diagnosis of idiopathic inflammatory myopathies Part II 28–30 March 2014, Naarden, The Netherlands 2014 ·Neuromuscular Disorders ·Jan De Bleecker,Boél De Paepe,Eleonora Aronica,Marjolein Visser,Anthony A. Amato,Olivier Benvéniste,Onno J. de Boer,Mazen M. Dimachkie,Romain K. Gherardi,Hans H. Goebel,David Hilton‐Jones,Janice L. Holton,Ingrid E. Lundberg,Andrew L. Mammen,Frank Mastaglia,Ichizo Nishino,Elisabeth J. Rushing,Henrik Daa Schrøder,Duygu Selcen,Werner Stenzel	96
14	The midbrain to pons ratio 2013 ·Neurology ·Luke A. Massey,Hans Rolf Jäger,Dominic Paviour,Sean S. O’Sullivan,Helen Ling,David R. Williams,Constantinos Kallis,Janice L. Holton,Tamás Révész,David J. Burn,Tarek Yousry,Andrew J. Lees,Nick C. Fox,Caroline Micallef	120
15	Morphometric analyses of normal pediatric brachial biceps and quadriceps muscle tissue. 2013 ·PubMed ·Adriana Maluf Elias Sallum,Hemlata Varsani,Janice L. Holton,Suely Kazue Nagahashi Marie,Lucy R. Wedderburn	15
16	Difference in MSA Phenotype Distribution between Populations: Genetics or Environment? 2012 ·Journal of Parkinson s Disease ·Tetsutaro Ozawa,Tamás Révész,Dominic Paviour,Andrew J. Lees,Niall Quinn,Mari Tada,Akiyoshi Kakita,Osamu Onodera,Koichi Wakabayashi,Hitoshi Takahashi,Masatoyo Nishizawa,Janice L. Holton	29
17	Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's diseasebreakdown → 2009 ·Brain ·(unknown),José Brás,Emma Deas,Sean S. O’Sullivan,Laura Parkkinen,Robin Lachmann,Abi Li,Janice L. Holton,Rita Guerreiro,Reema Paudel,(unknown),Andrew Singleton,Andrew J. Lees,John Hardy,Henry Houlden,Tamás Révész,Nicholas Wood	509
18	Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome 2007 ·Brain ·David R. Williams,Janice L. Holton,Catherine Strand,Alan Pittman,Rohan de Silva,Andrew J. Lees,Tamás Révész	303
19	Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonismbreakdown → 2005 ·Brain ·David R. Williams,Rohan de Silva,Dominic Paviour,Alan Pittman,Hilary Watt,Linda Kilford,Janice L. Holton,Tamás Révész,Andrew J. Lees	517
20	Familial cerebral amyloid angiopathy related to stroke and dementia. 2001 ·PubMed ·B Frangione,T Révész,Rubén Vidal,Janice L. Holton,Tammaryn Lashley,Henry Houlden,Nicholas Wood,Agueda Rostagno,Gordon T. Plant,Jorge Ghiso	23

About Janice L. Holton

Janice L. Holton is a scholar working on Neurology, Neurology and Cellular and Molecular Neuroscience, having authored 242 papers that have together received 17.7k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (129 papers), Alzheimer's disease research and treatments (64 papers) and Neurological disorders and treatments (54 papers). The work is most often cited by research in Neurology (11.6k citations), Neurology (3.9k citations) and Cellular and Molecular Neuroscience (4.6k citations). Janice L. Holton has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Tamás Révész, Andrew J. Lees, Tammaryn Lashley, Henry Houlden, Niall Quinn, Helen Ling, David R. Williams, John Hardy, Rohan de Silva and Peter Kempster. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact